Through the secretion of IL-17A and proinflammatory cytokines, Th17 cells are critical players in the pathophysiology of RA [4]–[6] and other inflammatory disorders, such as inflammatory bowel disease, psoriasis, and allograft rejection [3],[31]. Here, IL17A is linked to inflammatory bowel disease.